Leading organisations:
Glasgow Caledonian University (United Kingdom), Emschergenossenschaft (Germany), Université de Limoges (France), Lippeverband (Germany), Institute of Science and Technology (Luxembourg), and Dutch National Institute for Public Health and the Environment (The Netherlands)


Geographic Area:
British Isles Western Europe


To reduce the pollution in waters from pharmaceutical residues.

Target audience:
General Public, Health Professionals, Hospitals/health system stakeholders, National/Local decision and policy makers, Pharmaceutical manufacturers, Schools, Scientists, and Waste/water treatment providers

Area of interest:
Occurrence of pharmaceuticals in the environment, Pharmaceutical consumption by humans, Pharmaceutical manufacturing, Pharmaceutical waste & waste management, Risks to ecosystems, Risks to human health, Unused/expired pharmaceutical disposal practices, Wastewater, and Water treatment technologies


1) To develop measures complementing EU environmental policy and legislation (Water Framework Directive) in the area of protection of water-related species and enhancing biodiversity, 2) To promote responsible drug production and consumption patterns, 3) To promote eco-innovation, improved management tools for green technologies, lifecycle thinking and cleaner drug production processes, 4) To assist businesses in integrating/implementing innovative products, processes and services in their activities for technological improvements in wastewater treatment techniques and in pharmaceutical industries.

Communication material:

Return to search form.

HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.